Selected article for: "bacterial infection and COPD bacterial infection"

Author: Aran Singanayagam; Su-Ling Loo; Maria Calderazzo; Lydia J Finney; Maria-Belen Trujillo Torralbo; Eteri Bakhsoliani; Jason Girkin; Punnam Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew Reid; Joseph Foottit; Sebastian L Johnston; Nathan W Bartlett; Patrick Mallia
Title: Anti-microbial immunity is impaired in COPD patients with frequent exacerbations
  • Document date: 2019_5_9
  • ID: 72jzqm86_36
    Snippet: We next focused on other another AMP that could be important in driving secondary bacterial infection in COPD. A previous study reported that mannose-binding lectin (MBL)-2 polymorphisms with associated MBL-2 deficiency in serum is associated with recurrence of infective exacerbations in COPD 25 . Consistent with this report, we also found that MBL-2 concentrations in sputum were significantly reduced in frequent versus infrequent exacerbators at.....
    Document: We next focused on other another AMP that could be important in driving secondary bacterial infection in COPD. A previous study reported that mannose-binding lectin (MBL)-2 polymorphisms with associated MBL-2 deficiency in serum is associated with recurrence of infective exacerbations in COPD 25 . Consistent with this report, we also found that MBL-2 concentrations in sputum were significantly reduced in frequent versus infrequent exacerbators at stable state ( Figure 5a ) and also at 2 weeks post exacerbation onset (Figure 5b) , the same timepoint at which bacterial loads were increased.

    Search related documents:
    Co phrase search for related documents
    • associated serum deficiency polymorphism and serum deficiency: 1
    • bacterial infection and COPD bacterial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • bacterial infection and post exacerbation: 1, 2
    • bacterial infection and post exacerbation onset: 1
    • bacterial infection and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • bacterial infection and secondary COPD bacterial infection: 1, 2, 3, 4, 5, 6
    • bacterial infection and serum deficiency: 1
    • bacterial infection and sputum concentration: 1
    • bacterial infection and stable state: 1, 2, 3, 4, 5
    • bacterial load and previous study: 1, 2, 3
    • bacterial load and stable state: 1, 2
    • COPD bacterial infection and post exacerbation: 1
    • COPD bacterial infection and post exacerbation onset: 1
    • COPD bacterial infection and secondary COPD bacterial infection: 1, 2, 3, 4, 5, 6
    • COPD bacterial infection and stable state: 1, 2, 3
    • post exacerbation and secondary COPD bacterial infection: 1
    • post exacerbation and stable state: 1
    • post exacerbation onset and secondary COPD bacterial infection: 1
    • previous study and serum deficiency: 1